脳卒中研究班｜東京女子医科大学脳神経内科

2023

1	Hosoya M, Toi S, Seki M, Saito M, Hoshino T, Yoshizawa H, Kazuo Kitagawa K. Association between total cerebral small vessel disease score and cognitive function in patients with vascular risk factors. Hypertens Res, in press 2023
2	Toi S, Hosoya M, Ishizuka K, Hoshino T, Kitagawa K. Detection of atrial fibrillation and sinus pause in embolic stroke of undetermined sources by chest strap-style 7-Day Holter monitoring. Neurology and Clinical Neuroscience, in press 2023
3	Zhang X, Kira JI, Ogata H, Imamura T, Mitsuishi M, Fujii T, Kobayashi M, Kitagawa K, Namihira Y, Ohya Y, Maimaitijiang G, Yamasaki R, Fukata Y, Fukata M, Isobe N, Nakamura Y:Anti-LGI4 Antibody Is a Novel Juxtaparanodal Autoantibody for Chronic Inflammatory Demyelinating Polyneuropathy.　Neurol Neuroimmunol Neuroinflamm.;10(2):e200081. doi: 10.1212/NXI.0000000000200081,2023 Jan 11
4	北川一夫：トピックスVII 動脈硬化Update 脳血管病予防　日本内科学会雑誌　112; 2：202-208，2023

2022

1	Kitagawa K:Blood pressure management for secondary stroke prevention. Hypertens Res;45(6):936-943,2022 Jun
2	Kitagawa K, Arima H, Yamamoto Y, Ueda S, Rakugi H, Kohro T, Yonemoto K, Matsumoto M, Saruta T, Shimada K：Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study Group. Intensive or standard blood pressure control in patients　with a history of ischemic stroke: RESPECT post hoc analysis. Hypertens Res.;45(4):591-601,2022 Apr
3	Baba T, Takeda A, Murakami A, Koga T, Isomura T, Mori E, Hisanaga K, Ugawa Y, Hattori N, Murata M, Hasegawa K, Sobue G, Ito H, Yabe I, Yamamoto T, Iijima M, et al. Effect of donepezil for dementia prevention in Parkinson's disease with severe hyposmia (The DASH-PD study): A randomized long-term placebo-controlled trial. EClinicalMedicine;51:101571.doi:10.1016/ j.eclinm. 2022.101571,2022 Jul 14
4	Hoshino T, Mizuno T, Ishizuka K, Takahashi S, Arai S, Toi S, Kitagawa K:Triglyceride-glucose index as a prognostic marker after ischemic stroke or transient ischemic attack: a prospective observational study. Cardiovasc Diabetol. 2022 Nov 30;21(1):264. doi: 10.1186/s12933-022-01695-2
5	Hoshino T, Mizuno T, Nishimura A, Ishizuka K, Toi S, Takahashi S, Wako S, Kitagawa K：Reclassification and risk stratification of embolic stroke of undetermined source by ASCOD phenotyping. Int J Stroke. 11:17474930221096953. doi: 10.1177/17474930221096953,2022 May
6	Hoshino T, Ishizuka K, Toi S, Mizuno T, Nishimura A, Wako S, Takahashi S, Kitagawa K：Prognostic Role of Hypertriglyceridemia in Patients With Stroke of Atherothrombotic Origin. Neurology.;98(16):e1660-e1669,2022 Apr 19
7	Hoshino T, Ishizuka K, Toi S, Mizuno T, Nishimura A, Takahashi S, Wako S, Kitagawa K:Atherogenic Dyslipidemia and Residual Vascular Risk After Stroke or Transient Ischemic Attack. Stroke;53(1):79-86,2022 Jan
8	Hoshino T, Ishizuka K, Toi S, Seki M, Kitagawa K.： Effects of Pemafibrate in Patients with Stroke and Hypertriglyceridemia: Baseline Cerebral Artery Diseases and 3-Month Laboratory Outcomes. J Atheroscler Thromb.;29(7):1020-1030,2022 Jul 1
9	Ishizuka K, Hoshino T, Toi S, Mizuno T, Hosoya M, Saito M, Sato Y, Yagita Y, Todo K, Sakaguchi M, Ohashi T, Maruyama K, Hino S, Honma Y, Doijiri R, Yamagami H, Iguchi Y, Hirano T, Kimura K, Kitazono T, Kitagawa K:Remote ischemic conditioning for acute ischemic stroke part 2: Study protocol for a randomized controlled trial. Front Neurol.;13:946431. doi: 10.3389,2022 Aug 8
10	Ishizuka K, Saito M, Shibata N, Kitagawa K: Cytoskeletal protein breakdown and serum albumin extravasation in MRI DWI-T2WI mismatch area in acute murine cerebral ischemia. Neurosci Res. 2022 Nov 12:S0168-0102(22)00274-7. doi: 10.1016
11	Ishizuka K, Toi S, Hoshino T, Higuchi E, Kitagawa K：Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source. J Atheroscler Thromb.;29(5):785-793,2022 May 1
12	Kobayashi M, Takeuchi M, Suzuki M, Kitagawa K. Demyelinating neuropathy requires differential diagnosis with vasculitic neuropathy in rheumatoid arthritis: Significance of sural nerve electrophysiology findings. Clin Exp Neuroimmunol. https://doi.org/10.1111/cen3.12694, 2022 Feb
13	Kumano O, Suzuki S, Yamazaki M, An Y, Yasaka M, Ieko M：Japanese study group for the assessment of direct oral anticoagulants. Newly developed modified diluted prothrombin time reagent: A multi-centre validation in patients with non-valvular atrial fibrillation under direct oral anticoagulant therapy. Thromb Res 210:87-90,2022
14	Kumano O, Suzuki S, Yamazaki M, An Y, Yasaka M, Ieko M：Japanese study group for the assessment of direct oral anticoagulants. Evaluation of newly-developed modified diluted prothrombin time reagent in non-valvular atrial fibrillation patients with direct oral anticoagulants: A comparative study with conventional reagents. Int J Lab Hematol 16 September,2022
15	Mizuno T, Hoshino T, Ishizuka K, Toi S, Takahashi S, Wako S, Arai S, Kitagawa K:Hyperhomocysteinemia Increases Vascular Risk in Stroke Patients with Chronic Kidney Disease. J Atheroscler Thromb. 2022 Nov 26. doi: 10.5551/jat.63849.
16	Mizuno T, Hoshino T, Ishizuka K, Toi S, Nishimura A, Takahashi S, Wako S, Kitagawa K： Characteristics and Prognosis of Stroke in Living Donor Renal Transplant Recipients. J Atheroscler Thromb.;29(9):1393-1408,2022 Sep 1
17	Negishi N, Ikeguchi R, So H, Kobayashi M, Nitta M, Masui K, Nakamichi K, Takahashi K, Ishida H, Kawamata T, Shibata N, Shimizu Y, Kitagawa K. ：Successful treatment of progressive multifocal leukoencephalopathy that developed 21 years after renal transplantation: A case report. Neuroimmunology Reports.; 100113. doi: 10.1016/j.nerep.2022.100113 ,2022 Jul. 2
18	Niino M, Fukumoto S, Okuno T, Sanjo N, Fukaura H, Mori M, Ohashi T, Takeuchi H, Shimizu Y, Fujimori J, Kawachi I, Kira JI, Takahashi E, Miyazaki Y, Mifune N.　Correlation of the symbol digit modalities test with the quality of life and depression in Japanese patients with multiple sclerosis. Mult Scler Relat Disord.　;　57:103427,2022 Jan
19	Oshima R, Ikeguchi R, Wako S, Mizuno T, Abe K, Nitta M, Muragaki Y, Kawamata T, Masui K, Yamamoto T, Shibata N, Shimizu Y, Kitagawa K. IgG4-related brain pseudotumor mimicking CNS lymphoma. A case report. Neuropathology. Dec;42(6):526-533. doi: 10.1111,2022
20	Saito M, Hoshino T, Ishizuka K, Iwasaki S, Toi S, Shibata N, Kitagawa K. Remote Ischemic Conditioning Enhances Collateral Circulation Through Leptomeningeal Anastomosis and Diminishes Early Ischemic Lesions and Infarct Volume in Middle Cerebral Artery Occlusion. Transl Stroke Res. 2022 Nov 28. doi: 10.1007/s12975-022-01108-2.
21	Seki M, Yoshizawa H, Hosoya M, Kitagawa K. Neuropsychological Profile of Early Cognitive Impairment in Cerebral Small Vessel Disease. Cerebrovasc Dis.;51(5):600-607, 2022
22	Shimizu Y,　 Monoclonal antibody treatment for multiple sclerosis and　Neuromyelitis optica spectrum disorder: An update.　 Clinical and Experimental Neuroimmunology　;13（３）：131-132,2022
23	Shirai Y, Toi S, Adachi U, Tsutsumi Y, Kitagawa K. Cilostazol improves endothelial function in patients with ischemic stroke: A randomized controlled single-center study with flow-mediated dilation technique. J Neurol Sci. 15;439:120318. doi: 10.1016/j.jns.2022.120318,2022 Aug
24	Takahashi S, Ishizuka K, Hoshino T, Mizuno T, Nishimura A, Toi S, Kitagawa K. Long-Term Outcome in Patients With Acute Ischemic Stroke and Heart Failure. Circ J.. doi: 10.1253/circj.CJ-21-0937,2022 Apr 19
25	Takeda T, Iijima M, Seki M, Higuchi E, Shimizu Y, Shibata N, Kitagawa K. Prolonged central motor conduction time and pyramidal tract degeneration in amyotrophic lateral sclerosis. Clin Neuropathol.;41(4):157-161,2022 Jul-Aug
26	Toi S, Shirai Y, Ishizuka K, Hosoya M, Seki M, Higuchi E, Hoshino T, Kitagawa K.：Recurrent Stroke Incidence and Etiology in Patients with Embolic Stroke of Undetermined Source and Other Stroke Subtypes. J Atheroscler Thromb.;29(3):393-402,2022 Mar 1
27	Toyoda K, Omae K, Hoshino H, Uchiyama S, Kimura K, Miwa K, Minematsu K, Yamaguchi K, Suda Y, Toru S, Kitagawa K, Ihara M, Koga M, Yamaguchi T; CSPS.com Trial Investigators. Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis. Neurology 98(10):e983-e992，2022 Mar 8
28	Uchiyama S, Toyoda K, Okamura S, Omae K, Hoshino H, Kimura K, Kitagawa K, Minematsu K, Yamaguchi T:Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial. Int J Stroke. 17474930221112343. doi: 10.1177,2022 Jul 21
29	Wako S, Ikeguchi R, Toda K, Kobayashi M, Miyata R, Kuramochi H, Ichihara A, Shimizu Y, Kitagawa K. Characteristic cerebrospinal fluid findings in immune checkpoint inhibitor-related peripheral neuropathy: A case report. J Neuroimmunol ;374:578010. doi: 10.1016,2022 Dec 5
30	北川一夫：内科治療の変換と展望　最新臨床脳卒中学（第2版）上－最新の診断と治療－　日本臨牀社，日本臨床　80(増刊号1):14-21，2022.1.31
31	北川一夫：　RESPECT研究　最新臨床脳卒中学（第2版）下－最新の診断と治療－　日本臨牀社，日本臨床　80(増刊号2):548-553，2022.2.28
32	北川一夫：脳卒中ハイリスク患者選別のためのサロゲートマーカーの活用と1次予防の要点　Current Therapy ライフメディコム，40 (3); 55-61，2022.3
33	飯嶋　睦：嗅覚障害の病態と治療　神経変性疾患、アレルギーの臨床42(1):25-27北隆館，2022.1.20
34	斉藤聡志 , 飯嶋　睦, 関　美沙, 吉澤浩志, 北川一夫：周期性発射が持続した非けいれん性てんかん重積状態の離脱の評価にMRI arterial spin labeling が有用だった1例　臨床神経，62：49－52，2022
35	清水優子：免疫性神経疾患(第2 版)―基礎・臨床の最新知見-IX．トピックス・今知りたいこと妊娠・授乳中の免疫性神経疾患の治療方針　日本臨牀　80　(増刊５): 558-563，2022
36	清水優子：脊椎・脊髄障害Lhermitte徴候. Clinical　Neuroscience　40(11): 1382-1384 ，2022
37	清水優子：妊娠・授乳期の多発性硬化症・視神経脊髄炎スペクトラム障害（NMOSD）の免疫治療　神経内科　96 (4): 402-410，2022
38	清水優子：多発性硬化症診療の最新エビデンスと課題-多発性硬化症の妊娠、出産にかかわる諸問題と対処法　医学と薬学 79：473-479，2022
39	遠井素乃，北川一夫：脳卒中超音波診断の最近の動向　週刊医学のあゆみ　医歯薬出版株式会社，280(10):1000-1008，2022.3.5
40	星野岳郎：Residual risk beyond LDL-C：脳梗塞再発予防とatherogenic dyslipidemia　カレントテラピー 40: 80-86，2022
41	望月秀樹, 青木正志, 池中建介, 井上治久, 岩坪　威, 宇川義一, 岡澤　均, 小野賢二郎, 小野寺　理, 北川一夫, 齊藤祐子, 下畑享良, 髙橋良輔, 戸田達史, 中原仁, 松本理器, 水澤英洋, 三井　純, 村山繁雄, 勝野雅央, 日本神経学会将来構想委員会＜協力者＞青木吉嗣, 石浦　浩之, 和泉唯信, 小池春樹, 島田　斉, 髙橋祐二, 徳田隆彦, 中嶋秀人, 波田野　琢, 三澤園子, 渡辺宏久：脳神経疾患克服に向けた研究推進の提言2020，各論I（方法論別）臨床神経62：429-442，2022
42	望月秀樹, 青木正志, 池中建介, 井上治久, 岩坪　威, 宇川義一, 岡澤　均, 小野賢二郎, 小野寺　理, 北川一夫, 齊藤祐子, 下畑享良, 髙橋良輔, 戸田達史, 中原　仁, 松本理器, 水澤英洋, 三井　純, 村山繁雄, 勝野雅央, 日本神経学会将来構想委員会＜協力者＞青木吉嗣, 石浦　浩之, 和泉唯信, 小池春樹, 島田　斉, 髙橋祐二, 徳田隆彦, 中嶋秀人, 波田野　琢, 三澤園子, 渡辺宏久：脳神経疾患克服に向けた研究推進の提言2020，各論II（疾患群別）臨床神経，62：443-457，2022
43	若生　翔, 遠井素乃, 水野貴文, 西村絢子, 石塚健太郎, 北川一夫：Wall-eyed bilateral internuclear ophthalmoplegia（WEBINO）症候群を呈した心原性脳塞栓症の1例　臨床神経，62：541-545，2022

2021

1	Horisawa S, Fukui A, Hamahata H, Tanaka Y, Kuwano A, Momosaki O, Iijima M, Nanke M, Kawamata T, Taira T. Unilateral pallidothalamic tractotomy for akinetic-rigid Parkinson's disease: a prospective open-label study. J Neurosurg; 15;1-7,2021
2	Horisawa S, Yamaguchi Y, Abe K, Hori H, Fukui A , Iijima M, Sumi M, Hodotsuka K, Konishi Y, Kawamata T, Taira T. Magnetic resonance-guided focused ultrasound thalamotomy for focal fand dystonia: A pilot study. Mov Disord;36(8):1955-1959,2021
3	Horisawa S, Kitagawa K, Kawamata T, Taira T. Locomotor Recovery of Juvenile Huntington's Disease Treated by Pallidothalamic Tractotomy. Mov Disord;36(4):1028-1029,2021 Apr
4	Hoshino T, Uchiyama S, Wong LKS, Kitagawa K, Charles H, Labreuche J, Lavallée PC, Albers GW, Caplan LR, Donnan GA, Ferro JM, Hennerici MG, Molina C, Rothwell PM, Steg PG, Touboul PJ, Vicaut É, Amarenco P. Five-Year Prognosis After TIA or Minor Ischemic Stroke in Asian and Non-Asian Populations. Neurology; 96: e54-e66,2021
5	Iijima M, Okuma Y, Suzuki K, Yoshii F, Nogawa S, Osada T, Hirata K, Kitagawa K, Hattori N. Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson’s disease: a multicenter cross- sectional study. PLOS ONE; 16(2): e0247443,2021
6	Iijima M, Osawa M, Yasuda S, Kitagawa K. Association between excessive daytime sleepiness and the cholinergic ascending reticular system in Parkinson’s disease. Neurodegener Dis; 21(1-2):48-54,2021
7	Ikeguchi R, Shimizu Y, Kondo A, Kanda N, So H, Kojima H, Kitagawa K. Melanoma Cell Adhesion Molecule Expressing Helper T Cells in CNS Inflammatory Demyelinating Diseases. Neurol Neuroimmunol Neuroinflamm; 8 (6): e1069,2021
8	Ikeguchi R, Shimizu Y, Shimomura A, Suzuki M, Shimoji K, Motohashi T, Yamamoto T, Shibata N, Kitagawa K. Paraneoplastic AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder Associated With Teratoma: A Case Report and Literature Review. Neurol Neuroimmunol Neuroinflamm; 8 (5): e1045,2021
9	Kitazono T, Toyoda K, Kitagawa K, Nagao T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Ikeda Y, Shirai T, Abe K, Ogawa A; PRASTRO-I Study Group. Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial. J Atheroscler Thromb.;28(2):169-180,2021 Feb 1
10	Maeda Y, Toda K, Toi S, Yano T, Iijima M, Shimizu Y, Nagashima Y, Itakura Y, Iguchi S, Kikuchi K, Shibuya K, Nonaka M, Kitagawa K. Diagnostic Utility of Polymerase Chain Reaction for Paraffin-embedded Sinus Specimens for Rhinocerebral Mucormycosis Complicated by Internal Carotid Artery Thrombosis and Cerebral Infarction. Intern Med; 60: 2683-2686,2021
11	Masuda M, Iijima M, Ainoda Y, Hirai Y, Kikuchi K, Kitagawa K. Recurrent infections caused by different species of Neisseria bacteria in a patient with complement seven deficiency. eNeurologicalSci;22:00293,2021
12	So H, Ohashi T, Yamagishi S, Mori H, Takanashi J. Case of autoimmune glial fibrillary acidic protein astrocytopathy associated with Epstein-Barr virus reactivation. Clin Exp Neuroimmunol; 00: 1-5,2021
13	Todo K, Yoshimura S, Uchida K, Yamagami H, Sakai N, Kishima H, Mochizuki H, Ezura M, Okada Y, Kitagawa K, Kimura K, Sasaki M, Tanahashi N, Toyoda K, Furui E, Matsumaru Y, Minematsu K, Kitano T, Okazaki S, Sasaki T, Sakaguchi M, Takagaki M, Nishida T, Nakamura H, Morimoto T; RESCUE-Japan Registry 2 Investigators. Time-outcome relationship in acute large-vessel occlusion exists across all ages: subanalysis of RESCUE-Japan Registry 2. Sci Rep. 17;11(1):12782,2021 Jun
14	Toyoda K, Yamagami H, Kitagawa K, Kitazono T, Nagao T, Minematsu K, Uchiyama S, Tanahashi N, Matsumoto M, Nagata I, Nishikawa M, Nanto S, Shirai T, Abe K, Ikeda Y, Ogawa A; PRASTRO Trial Investigators*. Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I. Stroke; 52: 1234-1243,2021
15	Uchiyama S, Hoshino T, Charles H, Kamiyama K, Nakase T, Kitagawa K, Minematsu K, Todo K, Okada Y, Nakagawara J, Nagata K, Yamagami H, Yamaguchi T, Amarenco P. Japanese and Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: A Five-Year Risk Analysis of Stroke and Vascular Events. J Atheroscler Thromb; 28 656-664,2021
16	Watanabe M, Nakamura Y, Sato S, Niino M, Fukaura H, Tanaka M, Och Hi, Kanda T, Takeshita Y, Yokota T, Nishida Y, Matsui M, Nagayama S, Kusunoki S, Miyamot Ko, Mizuno M, Kawachi I, Saji E, Ohashi T, Shimohama S, Hisahara S, Nishiyama K, Iizuka T, Nakatsuji Y, Okuno T, Ochi K, Suzumura A, Yamamoto K, Kawano Y, Tsuji S, Hirata M, Sakate R, Kimura T, Shimizu Y, Nagaishi A, Okada K, Hayashi F, Sakoda A, Masaki K, Shinoda K, Isobe N,　Matsushita T and Kira J. HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data. Scientfic Reports; 11: 607. doi: 10.1038/s41598-020-79833-7,2021
17	Watanabe M, Nakamura Y, Sato S, Niino M, Fukaura H, Tanaka M, Ochi H, Kanda T, Takeshita Y, Yokota T, Nishida Y, Matsui M, Nagayama S, Kusunoki S, Miyamoto K, Mizuno M, Kawachi I, Saji E, Ohashi T, Shimohama S, Hisahara S, Nishiyama K, Iizuka T, Nakatsuji Y, Okuno T, Ochi K, Suzumura A, Yamamoto K, Kawano Y, Tsuji S, Hirata M, Sakate R, Kimura T, Shimizu Y, Nagaishi A, Okada K, Hayashi F, Sakoda A, Masaki K, Shinoda K, Isobe N, Matsushita T, Kira J.： HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data. Scientific Reports; 11: 607 ,2021
18	北川一夫：腎脳梗塞　「特集　腎臓病患者における脳心血管病と透析」　腎と透析　東京医学社，vol.90(1):58-63，2021
19	北川一夫：無症候性脳血管障害（未破裂脳動脈瘤を除く）　今日の治療指針2021年版　私はこう治療している　福井次矢，高木　誠、小室一成編　医学書院，pp954-956，ISBN：978-4-260-04283-3, 2021.1
20	北川一夫：脳梗塞　「特集　腎臓病患者における脳心血管病と透析」　腎と透析　東京医学社，vol.90(1):58-63，2021
21	北川一夫：抗血小板薬と抗凝固薬　BRAIN and NERVE，医学書院，73(9)：975-982，　ISSN：1881-6096，2021.9.1
22	北川一夫：脳血管障害　Clinical Neuroscience　中外医学社，Vol.39(9)：1140-11422021.9.1
23	北川一夫：脳梗塞　神経疾患最新の治療　2021-2023　園生雅弘，北川一夫，青木正志編　南江堂，東京， pp101-103，ISBN：978-4-524-22785-3，2021.2.20
24	北川一夫：最近の神経保護薬の臨床試験　脳卒中エキスパート　神経保護・神経再生療法〜今後の展望と課題　，鈴木則宏監　黒田　敏編　中外医学社，東京，pp85-90，ISBN978-4-498-32866-2，2021.4.30
25	北川一夫：脳血管障害　最新ガイドラインに基づく代謝・内分泌疾患診療指針 2021-’22　I．代謝疾患　４．糖尿病合併症　大血管障害　門脇　孝，下村伊一郎編　総合医学社，東京，pp109-115，ISBN978-4-88378-738-8，2021.9.25
26	北川一夫：抗血小板薬と抗凝固薬　BRAIN and NERVE　 73(9)：975-982　医学書院，　ISSN：1881-6096，2021.9.1
27	北川一夫：脳血管障害　Clinical Neuroscience Vol.39(9)：1140-1142　中外医学社，2021.9.1
28	飯嶋　睦：Parkinson病のバイオマーカーとしての嗅覚障害　脳神経内科 95 (6):768-772, 2021
29	飯嶋　睦：パーキンソン病の嗅覚障害　老年医学学会誌32 (7):701-705, 2021
30	飯嶋　睦：近い将来パーキンソン病の診断についてはAIが脳神経内科医を超える“No“. MDSJ Letters 14 (2):1-3, 2021
31	飯嶋　睦：合併症を有するParkinson病の薬剤選択　神経治療学 38 (4) 416-418, 2021
32	池口亮太郎，清水優子，柴田亮行：多発性硬化症と視神経脊髄炎　病理と臨床 39 (2)：185-191，2021
33	久保真人, 饗場郁子, 下畑享良, 服部信孝, 吉田一人, 海野佳子, 横山和正, 小川崇, 加世田ゆみ子, 小池亮子, 清水優子, 坪井義夫, 道勇学, 三澤園子, 宮地隆史, 戸田達史, 武田篤, 日本神経学会キャリア形成促進委員会　脳神経内科医におけるバーンアウト（第2報）―男性医師と女性医師の比較―　臨床神経学;61：219－227，2021
34	清水優子：脱髄性疾患の妊娠・授乳中の治療指針　日本臨床 79：1623-1630，2021
35	清水優子，藤原一男：VI.エイジング　８　多発性硬化症　視神経脊髄炎　Clinical euroscience;　39:99-102，2021
36	清水優子：MS/NMO 女性患者への診療アプローチ Annual Review　神経　荒木信夫，鈴木則宏編　中外医学社　 pp283-293，2021
37	下畑享良, 久保真人, 饗場郁子, 服部信孝, 吉田一人, 海野佳子, 横山和正, 小川崇, 加世田ゆみ子, 小池亮子, 清水優子, 坪井義夫, 道勇学, 三澤園子, 宮地隆史, 戸田達史, 武田篤, 日本神経学会キャリア形成促進委員会　脳神経内科医におけるバーンアウトの現状と対策―第1報―　臨床神経学;　61 :89-102，2021
38	遠井素乃, 北川一夫：脳卒中診療最前線　脳卒中の診療　一過性脳虚血発作　臨牀と研究　98巻12号1488-1492, 2021
39	遠井素乃：【手順が見える!わかる!　疾患・シーン別でもう迷わない　これ1冊で超安心!　脳神経疾患患者の観察・アセスメント】シーン別　観察・アセスメント　急に歩くとふらふらするようになった!! Brain Nursing2021夏季増刊　209-214, 2021
40	遠井素乃, 北川一夫：【脳卒中:内科医が知っておくべき最新診療】一次予防と再発予防　塞栓源不明脳塞栓症(ESUS)の再発予防　診断と治療109巻5号, 673-677, 2021
41	遠井素乃, 北川一夫：臨床医のための神経病理再入門　動脈硬化、塞栓症(ESUSを含む). Clinical Neuroscience　39巻1号13-15, 2021
42	遠井素乃，北川一夫：脳梗塞とは　Suzuken Medical vol.24(3) ：7　ライフメディコム, 2021
43	遠井素乃，北川一夫：脳梗塞のくすり　Suzuken Pharma vol.24(3)：7　ライフメディコム，2021
44	遠井素乃，北川一夫：脳卒中の診療　一過性脳虚血発作　臨牀と研究 98 (12) 1488-1492,　大道学舘出版部，2021.12
45	長尾毅彦，内山真一郎：日本における脳梗塞と心房細動ー発症率と重症度ー　あなたも名医！新しい経口抗凝固薬の適切な使い方　jmed mook; 21: 9-12， 2021
46	牧　千亜紀，清水優子，北川一夫，菅原京子：地域で生活する多発性硬化症のQOLに関する研究～SEIQoL-DW（個人の生活の質評価法）による分析～日本難病看護学会誌　;25(3),305-319，2021
47	水野貴文，石塚健太郎，北川一夫：特集Ⅱ　白質病変のupdate　高血圧脳症と後部可逆性脳症症候群　科学評論社，脳神経内科vol.94(5):649-655　 2021.5
48	水野貴文，石塚健太郎，北川一夫：高血圧脳症と後部可逆性脳症症候群脳神経内科　VOL94 NO.5 649-655，2021.5
49	吉澤浩志：一過性全健忘　Medical Practice　38(6): 956-958，2021
50	吉澤浩志, 北川一夫：アルツハイマー病の神経心理症状に対する脳小血管病の影響　Dementia Japan; 35(2): 186-195，2021
51	吉澤浩志：神経心理検査による認知症の早期診断と鑑別診断　Geriatric Medicine; 59(2): 195-199，2021

2020

1	Kitagawa K, Toyoda K, Kitazono T, Nishikawa M, Nanto S, Ikeda Y, Abe K, Ogawa A. Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II. Cerebrovasc Dis;49(2):152-159. doi: 10.1159/000506825,2020
2	Bahls M, Lorenz MW, Dörr M, Gao L, Kitagawa K, Tuomainen TP, Agewall S, Berenson G, Catapano AL, Norata GD, Bots ML, van Gilst W, Asselbergs FW, Brouwers FP, Uthoff H, Sander D, Poppert H, Hecht Olsen M, Empana JP, Schminke U, Baldassarre D, Veglia F, Franco OH, Kavousi M, de Groot E, Mathiesen EB, Grigore L, Polak JF, Rundek T, Stehouwer CD, Skilton MR, Hatzitolios AI, Savopoulos C, Ntaios G, Plichart M, McLachlan S, Lind L, Willeit P, Steinmetz H, Desvarieux M, Ikram MA, Johnsen SH, Schmidt C, Willeit J, Ducimetiere P, Price JF, Bergström G, Kauhanen J, Kiechl S, Sitzer M, Bickel H, Sacco RL, Hofman A, Völzke H, Thompson SG; PROG-IMT Study Group. Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium. Eur J Prev Cardiol. 2020 Feb;27(3):234-243. doi: 10.1177/2047487319877078.
3	Higuchi E, Kitagawa K. Response by Higuchi and Kitagawa to Letter Regarding Article, "Prevalence of Microembolic Signals in Embolic Stroke of Undetermined Source and Other Subtypes of Ischemic Stroke". Stroke. 2020 Apr;51(4):e63. doi: 10.1161/STROKEAHA.120.028822
4	Higuchi E, Toi S, Shirai Y, Hoshino T, Ishizuka K, Shimizu S, Tsutsumi Y, Kitagawa K. Prevalence of Microembolic Signals in Embolic Stroke of Undetermined Source and Other Subtypes of Ischemic Stroke. Stroke;51(2):655-658,2020 Feb
5	Hosomi N, Kitagawa K, Nagai Y, Nakagawa Y, Aoki S, Nezu T, Kagimura T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Matsumoto M:for J-STARS collaborators. Different Influences of Statin Treatment in Preventing At-Risk Stroke Subtypes: A Post Hoc Analysis of J-STARS. J Atheroscler Thromb. 1;27(5):449-460. doi: 10.5551/jat.50518,2020 May
6	Horisawa S, Fukui A, Hamahata H, Tanaka Y, Kuwano A, Momosaki O, Iijima M, Nanke M, Kawamata T, Taira T. Unilateral pallidothalamic tractotomy for akinetic-rigid Parkinson's disease: a prospective open-label study. J Neurosurg; 15;1-7 ， 2021
7	Kitano T, Todo K, Yoshimura S, Uchida K, Yamagami H, Sakai N, Sakaguchi M, Nakamura H, Kishima H, Mochizuki H, Ezura M, Okada Y, Kitagawa K, Kimura K, Sasaki M, Tanahashi N, Toyoda K, Furui E, Matsumaru Y, Minematsu K, Morimoto T. Futile complete recanalization: patients characteristics and its time course. Sci Rep. 2020 Mar 18;10(1):4973. doi: 10.1038/s41598-020-61748-y
8	Kitazono T, Toyoda K, Kitagawa K, Nagao T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Ikeda Y, Shirai T, Abe K, Ogawa A; PRASTRO-I Study Group. Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial. J Atheroscler Thromb. doi: 10.5551/jat.56093. 2020 Jun 4
9	Kondo A, Ikeguchi R, Shirai Y, Kobayashi M, Toi S, Shimizu Y, Kitagawa K. Association of IgG4-Related Arteritis With Recurrent Stroke. J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104514. doi: 10.1016
10	Nagasaka T, Hata T, Shindo K, Adachi Y, Takeuchi M, Saito K, Takiyama Y.：Morphological Alterations of the Sarcotubular System in　Permanent Myopathy of Hereditary Hypokalemic Periodic Paralysis with a Mutation in the CACNA1S Gene. J Neuropathol Exp Neurol. 2020 79(12):1276-1292
11	Nezu T, Hosomi N, Kitagawa K, Nagai Y, Nakagawa Y, Aoki S, Kagimura T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Matsumoto M; J-STARS collaborators. Effect of Statin on Stroke Recurrence Prevention at Different Infarction Locations: A Post Hoc Analysis of The J-STARS Study. J Atheroscler Thromb. 2020 Jun 1;27(6):524-533. doi: 10.5551/jat.51391.
12	Niida-Kawaguchi M, Kakita A, Noguchi N, Kazama M, Masui K, Kato Y, Yamamoto T, Sawada T, Kitagawa K, Watabe K, Shibata N. Soluble iron accumulation induces microglial glutamate release in the spinal cord of sporadic amyotrophic lateral sclerosis. Neuropathology;40(2):152-166. doi: 10.1111/neup.12632,2020 Apr
13	Oyama M, Okada K, Masuda M, Shimizu Y, Yokoyama K, Uzawa A, Kawaguchi N, Ikeguchi R, Hoshino Y, Hatano T, Ozawa Y, Nakahara J, Aizawa H, Kitagawa K, Hattori N, Kuwabara S, Murai H, Suzuki S. ：Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis. Ther Adv Neurol Disord. 2020 Mar 18;13:1756286420904207. doi: 10.1177/1756286420904207. eCollection,2020
14	Shindo A, Tabei KI, Taniguchi A, Nozaki H, Onodera O, Ueda A, Ando Y, Urabe T, Kimura K, Kitagawa K, Hanyu H, Hirano T, Wakita H, Fukuyama H, Kagimura T, Miyamoto Y, Takegami M, Saito S, Watanabe-Hosomi A, Mizuta I, Ihara M, Mizuno T, Tomimoto H. A Nationwide Survey and Multicenter Registry-Based Database of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy in Japan. Front Aging Neurosci. 2020 Jul 14;12:216.
15	Shirai Y, Toi S, Adachi U, Kitagawa K：Impaired Endothelial Function in Embolic Stroke of Undetermined Source.　J Stroke Cerebrovasc Dis.Jan;29(1):104489,2020
16	Takeda T, Kitagawa K, Arai K：Phenotypic variability and its pathological basis in amyotrophic lateral sclerosis. Neuropathology.;40(1):40-56. doi: 10.1111/neup.12606,2020 Feb
17	Tahara M, Oeda T, Okada K, Kiriyama T, Ochi K, Maruyama H, Fukaura H, Nomura K, Shimizu Y, Mori M, Nakashima I, Misu T, Umemura A, Yamamoto K, Sawada H. Safety and Efficacy of Rituximab in Neuromyelitis Optica Spectrum Disorders (RIN-1 Study): A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial. Lancet Neurol.　2020. 19:298 - 306
18	Uchiyama S, Yamazaki M, Ishikawa T, Yamaguchi K, Kawamata T. Diagnosis and management of Moyamoya disease. Case Rep Neurol. 2020;12;137-142
19	Yamazaki M. Monitoring of Antithrombotic Therapy. J Atheroscler Thromb.;27:201-3,2020
20	北川一夫：脳卒中慢性期治療　「Clinical Neuroscience」　中外医学社、　38(5):564-567，2020
21	北川一夫：RESPECT研究：脳卒中再発予防の降圧レベル　週刊医学のあゆみ　医歯薬出版株式会社　272(12)：1217-1219，2020
22	北川一夫：5章7：『脳卒中と脂質異常症の関係，脳血管疾患患者に対する脂質異常症管理について教えて下さい』　「評価・処方の“いま”を押さえる　見直し！脂質異常症」　日本医事新報社　70:165-169，2020.10
23	北川一夫：RESPECT研究：脳卒中再発予防の降圧レベル　「週刊医学のあゆみ」　医歯薬出版，　272(12):1217-1219,　2020.3.21
24	北川一夫：積極的降圧療法の脳卒中再発予防効果に関する多施設共同無作為化比較試験(RESPECT STUDY) Annual Review 神経2020　集　鈴木則宏，荒木信夫，宇川義一，桑原　聡，塩川芳昭編，中外医学社，東京，pp160-166，ISBN：978-4-498-32848-8 ，2020.4.15
25	北川一夫：他科の視点からSGLT2阻害薬の臨床的位置づけを探る　脳卒中・脳神経内科からみた考え方、使い方　ひと味違うSGLT2阻害薬の使い方　野出孝一監　豊田　茂，井上晃男編　中外医学社，東京，pp111-114，ISBN：978-4-498-12390-8，2020.4.10
26	北川一夫：RESPECT研究　高血圧学（下）―高血圧制圧の現状と展望―　楽木宏美編　日本臨床社，東京，pp526-531　ISSN 0047-1852，2020.7.31
27	飯嶋　睦，戸田普央：整形外科で気づきにくい神経内科疾患　関節外科39: 120-6, 2020
28	飯嶋　睦：パーキンソン病、アルツハイマー病の嗅覚障害の特徴　Aroma Research 82: 14-19，2020
29	飯嶋　睦：パーキンソン病の治療―MAOB阻害薬の位置づけー　さいたま市与野医師会報 58: 187-190，2020
30	清水優子：妊娠・授乳期の多発性硬化症・視神経脊髄炎スペクトラム障害（NMOSD）の免疫療法. 神経内科 96：402-410，2020
31	清水優子：免疫性神経疾患の治療薬　「妊娠と授乳　改定第3版」　伊藤真也，村島温子編　南山堂　pp563-572，2020
32	山崎昌子, 松本雅則，加藤　恒：2019 Hot Topics　血小板分野　血栓止血誌　;31:81-83，2020

2019

1	Kitagawa K, Yamamoto Y, Arima H, Maeda T, Sunami N, Kanzawa T, Eguchi K, Kamiyama K, Minematsu K, Ueda S, Rakugi H, Ohya Y, Kohro T, Yonemoto K, Okada Y, Higaki J, Tanahashi N, Kimura G, Umemura S, Matsumoto M, Shimamoto K, Ito S, Saruta T, Shimada K; Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study Group. Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke: A Randomized Clinical Trial and Meta-analysis. JAMA Neurol. 76:1309-1318,2019
2	Kitagawa K, Hosomi N, Nagai Y, Kagimura T, Ohtsuki T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Nakamura M, Matsumoto M:J-STARS collaborators. Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA. J Atheroscler Thromb. 2019 May 1;26(5):432-441
3	Uchiyama S, Hoshino T, Sissani L, Linsay MT, Kamiyama K, Nakase T, Kitagawa K, Minematsu K, Todo K, Okada Y, Nakagawara J, Nagata K, Yamagami H, Yamaguchi T, Amarenco P; TIAregistry.org Investigators Japanese Versus Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: Subanalysis of TIA registry.org. J Stroke Cerebrovasc Dis. Aug;28(8):2232-2241 ,2019
4	Uchiyama S, Toyoda K, Kitagawa K, Okada Y, Ameriso S, Mundl H, Berkowitz S, Yamada T, Liu YY, Hart RG; NAVIGATE ESUS Investigators. Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS. Int J Stroke. Dec;14(9):915-922,2019
5	Higuchi E, Toi S, Shirai Y, Mizuno S, Onizuka H, Nagashima Y, Hashimoto K, Kitagawa K. Recurrent Cerebral Infarction Due to Benign Uterine Myoma. J Stroke Cerebrovasc Dis.; 28(1) :e1-e2,2019
6	Hoshino T, Toi S, Toda K, Uchiyama Y, Yoshizawa H, Iijima M, Shimizu Y,Kitagawa K. Ischemic Stroke due to Virologically-Confirmed Varicella Zoster Virus Vasculopathy: A Case Series. J Stroke Cerebrovasc Dis. Feb;28(2):338-343 ,2019
7	Iijima M, Orimo S, Terashi H, Suzuki M, Hayashi A, Shimura H, Mitoma H, Kitagawa K, Okuma Y. Efficacy of istradefylline for gait disorders with freezing of gait in Parkinson's disease: A single-arm, open-label, prospective, multicenter study. Expert Opin Pharmacother.;20(11):1405-1411,2019 Aug
8	Iijima M, Oguni H, Kobayashi M, Kitagawa K: Perampanel improved intractable myoclonus in two patients with myoclonus epilepsy.　 eNeurologicalSci. 2019 Nov 18;17:100215. doi: 10.1016/j.ensci.2019.100215. eCollection 2019 Dec. 22.
9	Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators:Achieving LDL-C target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients With Hypercholesterolemia and Diabetic Retinopathy Study. Diabetes Obes Metab. 21(4): 791-800, 2019
10	Kubota M, Iijima M, Shirai Y, Toi S, Kitagawa K. Association Between Cerebral Small Vessel Disease and Central Motor Conduction Time in Patients with Vascular Risk. J Stroke Cerebrovasc Dis;28(8):2343-2350, 2019 Aug
11	Miwa K, Yagita Y, Sakaguchi M, Kitagawa K, Sakai N, Mochizuki H. Effect of Enzyme Replacement Therapy on Basilar Artery Diameter in Male Patients With Fabry Disease. Stroke.;50(4):1010-1012,2019 Apr
12	Niino M, Fukazawa T, Kira JI, Okuno T, Mori M, Sanjo N, Ohashi T, Fukaura H, Fujimori J, Shimizu Y, Mifune N, Miyazaki Y, Takahashi E, Kikuchi S, Langdon D, Benedict RH, Matsui M:Cognition with magnetic resonance imaginh findings and social activities in patients with multiple sclerosis in Japanese cohort. Clinical & Experimental Neuroimmunology.; 10(1):41-48,2019
13	Ogawa A, Toyoda K, Kitagawa K, Kitazono T, Nagao T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Abe K, and Ikeda Y; PRASTRO-I Study Group: Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke : a phase 3, randomised, non-inferiority trial (PRASTRO-I) Lancet Neurol;18(3):238-247,2019 Mar
14	Saito M, Ishizuka K, Hoshino T, Toi S, Kitagawa K:Leptomeningeal anastomosis and early ischemic lesions on diffusion-weighted imaging in male murine focal cerebral ischemia. J Neurosci Res.;97(7):752-759,2019 Jul
15	Sakamoto Y, Nishiyama Y, Iwasaki YK, Daida H, Toyoda K, Kitagawa K, Okumura K, Kusano K, Hagiwara N, Fujimoto S, Miyamoto S, Otsuka T, Iguchi Y, Kanamaru T, Yamamoto T, Kaburagi J, Kimura T, Matsumoto T, Kimura K, Shimizu W; STABLED Study Investigators. Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study. J Cardiol. 74(6): 539-542, 2019
16	So H, Ikeguchi R, Kobayashi M, Suzuki M, Shimizu Y, Kitagawa K. PD-1 inhibitor-associated severe myasthenia gravis with necrotizing myopathy and myocarditis. J Neurol Sci. 2019 Apr 15;399:97-100.
17	Suzuki M, Said G. ：Chronic inflammatory demyelinating polyneuropathy. Neuroimmune diseases from cells to the living brain, Eds: Mitoma H, Manto M. Springer 2019: 737-764,2019
18	Takeda T, Iijima M, Shimizu Y, Yoshizawa H, Miyashiro M, Onizuka H, Yamamoto T, Nishiyama A, Suzuki N, Aoki M, Shibata N, Kitagawa K. p.N345K mutation in TARDBP in a patient with familial amyotrophic lateral sclerosis: An autopsy case. Neuropathology;39(4):286-293,2019 Aug
19	Takeuchi M, Miwa K, Tanaka M, Zhou Y, Todo K, Sasaki T, Sakaguchi M, Kitagawa K, Mochizuki H. A 9-Year Longitudinal Study of Basilar Artery Diameter. J Am Heart Assoc.;8(5):e011154. doi: 10.1161/JAHA.118.011154. 2019 Mar 5
20	Tanaka T, Yamagami H, Ihara M, Miyata T, Miyata S, Hamasaki T, Amano S, Fukuma K, Yamamoto H, Nakagawara J, Furui E, Uchiyama S, Hyun B, Yamamoto Y, Manabe Y, Ito Y, Fukunaga R, Abumiya T, Yasaka M, Kitagawa K, Toyoda K, Nagatsuka K. Association of CYP2C19 Polymorphisms With Clopidogrel Reactivity and Clinical Outcomes in Chronic Ischemic Stroke. Circ J.;83(6):1385-1393,2019 May 24
21	Toda K, Iijima M, Kitagawa K. Periventricular White Matter Lesions Influence Gait Functions in Parkinson's Disease. Eur Neurol 81: 120-127,2019 Jun
22	Wada S, Koga M, Minematsu K, Toyoda K, Suzuki R, Kagimura T, Nagai Y, Aoki S, Nezu T, Hosomi N, Origasa H, Ohtsuki T, Maruyama H, Yasaka M, Kitagawa K, Uchiyama S, Matsumoto M. Baseline Carotid Intima-Media Thickness and Stroke Recurrence During Secondary Prevention With Pravastatin. Stroke.;50(6):1586-1589, 2019 Jun
23	Yagita Y, Sakai N, Miwa K, Ohara N, Tanaka M, Sakaguchi M, Kitagawa K, Mochizuki H. Magnetic Resonance Imaging Findings Related to Stroke Risk in Japanese Patients With Fabry Disease. Stroke;50(9):2571-2573,2019 Sep
24	Yokoyama M, Mizuma A, Terao T, Tanaka F, Nishiyama K, Hasegawa Y, Nagata E, Nogawa S, Kobayashi H, Yanagimachi N, Okazaki T, Kitagawa K, Takizawa S; CMB-NOW Study Investigators. Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial. J Stroke Cerebrovasc Dis.;28(7):1918-1925,2019 Jul
25	北川一夫：（特集）脳血管の過去・現在・未来　炎症とバイオマーカー　「分子脳血管病」　先端医学社、　vol.18(1):14-18，2019.1
26	北川一夫：「一過性脳虚血発作の内科的治療」　「今日の治療指針2019年版　私はこう治療している」　医学書院　総編集：福井次矢，高木　誠，小室一成　2019.1.16　pp911-912　ISBN：978-4-260-03650-4
27	北川一夫：塞栓源不明の脳梗塞(ESUS).　「Clinical Neuroscience 」中外医学社、　37(3) 356-357，2019.3
28	北川一夫：脳卒中。　「ガイドライン外来診療2019　今日の診療のために」　　　泉　孝英編　日本メディカル開発，pp 520-524，ISBN：978-4-931400-92-4，2019.3.4
29	北川一夫：RESPECT試験　「カレントテラピー」　ライフメディコム， 37 (6); 77，2019.6
30	北川一夫：認知症と炎症マーカー　「最新医学」　最新医学社，74 (6): 755-760，2019.6
31	北川一夫, 石塚健太郎, 斎藤萌子, 星野岳郎, 遠井素乃：虚血ペナンブラ　「日本臨牀」　日本臨牀社，77(6): 906-913，2019.6
32	北川一夫：一過性脳虚血発作（TIA）の特徴　「脳卒中　基礎知識から最新リハビリテーションまで」　医歯薬出版、pp37-39，2019.6
33	北川一夫：脳卒中診療Uo-To-Date　-再発予防～慢性期治療まで- 「東京都医師会雑誌」　東京都医師会　72 (7); 31-35，2019.8
34	北川一夫：塞栓源不明の脳塞栓症(ESUS)　動脈硬化診療のすべて　「日本医師会雑誌」　日本医師会、　148(2);337-339，2019.10
35	北川一夫：塞栓源不明の脳梗塞　「Medeical Practice」　文光堂，36(12):1942-1944， 2019.12
36	北川一夫：《スタチンを誰にどのように使うのか？》８．脳血管疾患予防にスタチンは有効ですか？脳出血のリスクはないのでしょうか？　スタチンを使いこなす！18のクリニカル・パールズ　小倉正恒企画編集　新興医学出版社，東京，pp186-188，2019
37	北川一夫：脳静脈・静脈洞閉塞症への抗血栓療法　脳卒中エキスパート　抗血栓療法を究める　鈴木則宏監，伊藤義彰編　中外医学社，東京，pp200-213，ISBN：978-4-498-32822-8，2019.1.28
38	飯嶋　睦：ヘルスケアに重点を置いた神経疾患の予防日本人Parkinson病患者に適した運動療法の普及　神経内科治療学 36 (1) : 24, 2019
39	國島伸治, 山崎昌子, 松本雅則：2018 Hot Topics　血小板分野血栓止血誌　30:248-51，2019
40	板口典弘, 森　真由子, 内山由美子, 吉澤浩志, 小池康晴, 福澤一吉：書字障害の定量的評価　タブレットを用いた位置と時間の解析，高次脳機能研究39（4），436-443，2019
41	清水優子：性差医療（６）免疫性神経疾患　妊娠・出産のマネージメント　東京女子医大学会誌.89:115-126，2019
42	清水優子：医事新報　質疑応答プロからプロへ「多発性硬化症患者の妊娠・出産時の治療について」　日本医事新報　No.4970:46-47，2019
43	清水優子：免疫抑制薬投与中の患者管理について神経治療学.36:422-427，2019
44	清水優子：妊娠・出産における注意事項について教えてください MG　Frontier. １：30-31，2019
45	清水優子：NMO-SDにおける血清Leptin.　神経内科.　90:72-77，2019
46	星野岳郎，北川一夫：脳梗塞「症例から学ぶ戦略的急性期脳卒中診断・治療」　伊藤義彰編　南山堂，pp122-150，ISBN：978-4-525-24931-1，2019.3
47	山崎昌子：脳梗塞のマネジメントについて教えてください　Frontiers in Haemophilia　6:31-2，2019
48	山崎昌子：血栓止血の臨床-研修医のために第2版　血栓性疾患の治療薬．脳血管障害における抗血栓療法　血栓止血誌　30:130-4，2019
49	山崎昌子，内山真一郎：医薬品副作用学(第3版)上-薬剤の安全使用アップデート-　薬効群別副作用　抗血栓薬(抗血小板薬、抗凝固薬、血栓溶解薬)　日本臨床77増刊3　医薬品副作用学（上）:216-22，2019

2018

1	Kitagawa K, Saitoh M, Ishizuka K, Shimizu S:Remote Limb Ischemic Conditioning during Cerebral Ischemia Reduces Infarct Size through Enhanced Collateral Circulation in Murine Focal Cerebral Ischemia. J Stroke Cerebrovasc Dis. 2018 Apr;27(4):831-838
2	Hosomi N, Nagai Y, Kitagawa K, Nakagawa Y, Aoki S, Nezu T, Kagimura T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Matsumoto M; J-STARS collaborators. Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event. J Atheroscler Thromb. 1;25(3):262-268,2018 Mar
3	Hosomi N, Kitagawa K, Nagai Y, Nakagawa Y, Aoki S, Nezu T, Kagimura T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Matsumoto M; J-STARS Collaborators. Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke). Stroke.;49(4):865-871,2018 Apr
4	Ikeguchi R, Shimizu Y, Abe K, Shimizu S, Maruyama T , Nitta M, Abe K, Kawamata T, Kitagawa．Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas. Mult Scler Relat Disord 26:77-84 ,2018 Nov
5	Ikeguchi R, Shimizu Y, Shimizu S, Kitagawa K:CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma. Mult Scler.; 24(9): 1212-1223 ,2018
6	Ishizuka K, Hoshino T, Ashihara K, Maruyama K, Toi S, Mizuno S, Shirai Y, Hagiwara N, and Kitagawa K. Associations of Mitral and Aortic Valve Calcifications with Complex Aortic Atheroma in Patients with Embolic Stroke of Undetermined Source J Stroke Cerebrovasc Dis.;27(3):697-702,2018 Mar
7	Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators. Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study.　Diabetes Care.;41(6):1275-1284,2018 Jun
8	Koga M, Toyoda K, Minematsu K, Yasaka M, Nagai Y, Aoki S, Nezu T, Hosomi N, Kagimura T, Origasa H, Kamiyama K, Suzuki R, Ohtsuki T, Maruyama H, Kitagawa K, Uchiyama S, Matsumoto M; J-STARS Investigators. Long-Term Effect of Pravastatin on Carotid Intima-Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke). Stroke.;49(1):107-113,2018 Jan
9	Lorenz MW, Gao L, Ziegelbauer K, Norata GD, Empana JP, Schmidtmann I, Lin HJ, McLachlan S, Bokemark L, Ronkainen K, Amato M, Schminke U, Srinivasan SR, Lind L, Okazaki S, Stehouwer CDA, Willeit P, Polak JF, Steinmetz H, Sander D, Poppert H, Desvarieux M, Ikram MA, Johnsen SH, Staub D, Sirtori CR, Iglseder B, Beloqui O, Engström G, Friera A, Rozza F, Xie W, Parraga G, Grigore L, Plichart M, Blankenberg S, Su TC, Schmidt C, Tuomainen TP, Veglia F, Völzke H, Nijpels G, Willeit J, Sacco RL, Franco OH, Uthoff H, Hedblad B, Suarez C, Izzo R, Zhao D, Wannarong T, Catapano A, Ducimetiere P, Espinola-Klein C, Chien KL, Price JF, Bergström G, Kauhanen J, Tremoli E, Dörr M, Berenson G, Kitagawa K, Dekker JM, Kiechl S, Sitzer M, Bickel H, Rundek T, Hofman A, Mathiesen EB, Castelnuovo S, Landecho MF, Rosvall M, Gabriel R, de Luca N, Liu J, Baldassarre D, Kavousi M, de Groot E, Bots ML, Yanez DN, Thompson SG; PROG-IMT study group.　 Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration.　 PLoS One. 12;13(4):e0191172. doi: 10.1371/journal.pone.0191172. eCollection 2018,2018 Apr
10	Nagao T, Toyoda K, Kitagawa K, Kitazono T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Abe K, Ikeda Y, Ogawa A. A noninferiority confirmatory trial of prasugrel versus clopidogrel in Japanese patients with non-cardioembolic stroke: rationale and study design for a randomized controlled trial - PRASTRO-I trial. Expert Opin Pharmacother.;19(6):529-535,2018 Apr
11	Nakamura M, Fukukawa T, Kitagawa K, Nagai Y, Hosomi N, Minematsu K, Uchiyama S, Matsumoto M, Miyamoto Y; for J-STARS collaborators. Ten-year standardization of lipids and high-sensitivity C-reactive protein in a randomized controlled trial to assess the effects of statins on secondary stroke prevention: Japan Statin Treatment Against Recurrent Stroke. Ann Clin Biochem.;55(1):128-135 ,2018 Jan
12	Niino M, Ohashi T, Ochi H, Nakashima I, Shimizu Y, Matsui M: Japanese guidelines for dimethyl fumarate. Clinical and Experimental Neuroimmunology　：9 (4)：235-243, 2018
13	Niino M, Fukazawa T, Kira J, Okuno, T, Mori M, Sanjo, N, Ohashi T, Fukaura H, Fujimori J, Shimizu Y, Mifune N, Miyazaki Y, Takahashi E, Kikuchi S, Langdon D, Benedict R, Matsui M: Cognition with magnetic resonance imaging findings and social activities in patients with multiple sclerosis in a Japanese cohort．Clinical and Experimental Neuroimmunology　2018:19：9 (4)：doi.org/10.1111/cen3.12484（Cite Score 0.41）, 2018 Nov
14	Nishimura　A, Ikeguchi　R, Kobayashi　M, Takeuchi　M, Shimizu　Y, Saigusa　H, Kitagawa　K: Chronic sarcoid myopathy manifesting only as dysphagia and dysarthria in an 84-yearold woman．Clin Neurol Neurosurg.2018 Oct;173:58-60. doi: 10.1016/j.clineuro.2018.07.018. Epub ,2018 Jul 26
15	Nohara A, Ohmura H, Okazaki H, Ogura M, Kitagawa K, Koseki M, Sato K, Tsukamoto K, Yamashita S: Japan Atherosclerosis Society Working Group on Statement for Appropriate Use of PCSK9 Inhibitors. Statement for Appropriate Clinical Use of PCSK9 Inhibitors. J Atheroscler Thromb. 1;25(8):747-750,2018 Aug
16	Obayashi T, Takeda T, Iijima M, Shimizu Y, Yoshizawa H, Kitagawa K:Unilateral flapping tremor associated with internal carotid artery stenosis–A subtype of limb shaking. Eur J Neurol.; 25(5):e56-e57,2018
17	Saji N, Sakurai T, Ito K, Tomimoto H, Kitagawa K, Miwa K, Tanaka Y, Kozaki K, Kario K, Eto M, Suzuki K, Shimizu A, Niida S, Hirakawa A, Toba K: Strawberry study investigators. Protective effects of oral anticoagulants on cerebrovascular diseases and cognitive impairment in patients with atrial fibrillation: protocol for a multicentre, prospective, observational, longitudinal cohort study (Strawberry study). BMJ Open. 25;8(11):e021759. doi: 10.1136/bmjopen-2018-021759,2018 Nov
18	Seki M, Takeda T, Ito E, Iijima M, Kitagawa K:Mimicking Adie's pupils in the early phase of meningeal neurosyphilis. Neurology and Clinical Neuroscience, 6(2): doi: 10.1111/ncn3.12185,2018 Jan 15
19	Shirai, Y. Uchiyama, Y. Kobayashi, M. Ito, E. Uchiyama, S. Shimizu, Y. Kitagawa, K, A case of post-Lyme disease syndrome (PLDS) involving motor neuropathy and myositis, Mathew Journal of Neurology 3(1), 1-5, 2018
20	Suzuki K, Miyamoto M, Miyamoto T, Matsubara T,Inoue Y, Iijima M, Mizuno S, Horie J, Hirata K, Shimizu T, Kanbayashi T: Cerebrospinal fluid orexin-A levels in systemic lupus erythematosus patients presenting with excessive daytime sleepiness. Lupus: 1–7,2018
21	Suzuki K, Miyamoto M, Miyamoto T, Matsubara T,Inoue Y, Iijima M, Mizuno S, Horie J, Hirata K, Shimizu T, Kanbayashi T: Cerebrospinal fluid orexin-A levels in systemic lupus erythematosus patients presenting with excessive daytime sleepiness. Lupus Oct;27(11):1847-53, 2018
22	Suzuki M, Yogo M, Morita M, Terashi H, Iijima M, Yoneyama M, Takada M, Utsumi H, Okuma Y, Hayashi A, Orimo S, Mitoma H: A proposal for new algorithm that defines gait-induced acceleration and gait cycle in daily parkinsonian gait disorders. DOI: 10.5772/intechopen.75483, In book: Wearable Technologies, P25-48,2018 Oct
23	Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, Ogawa T, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Yamazaki T, Ito H, Otsuji Y, Kimura K, Takahashi J, Hirayama A, Yokoi H, Kitagawa K, Urabe T, Okada Y, Terayama Y, Toyoda K, Nagao T, Matsumoto M, Ohashi Y, Kaneko T, Fujita R, Ohtsu H, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Inoue T, Matsuzaki M, Nagai R: High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial. Circulation.;137(19):1997-2009, 2018 May 8
24	Wada S, Koga M, Toyoda K, Minematsu K, Yasaka M, Nagai Y, Aoki S, Nezu T, Hosomi N, Kagimura T, Origasa H, Kamiyama K, Suzuki R, Ohtsuki T, Maruyama H, Kitagawa K, Uchiyama S, Matsumoto M: Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study Collaborators. Factors Associated with Intima-Media Complex Thickness of the Common Carotid Artery in Japanese Noncardioembolic Stroke Patients with Hyperlipidemia: The J-STARS Echo Study. J Atheroscler Thromb.;25(4):359-373,2018 Apr 1
25	Yoshimura S, Sakai N, Uchida K, Yamagami H, Ezura M, Okada Y, Kitagawa K, Kimura K, Sasaki M, Tanahashi N, Toyoda K, Furui E, Matsumaru Y, Minematsu K, Morimoto T: Endovascular Therapy in Ischemic Stroke With Acute Large-Vessel Occlusion: Recovery by Endovascular Salvage for Cerebral Ultra-Acute Embolism Japan Registry 2. J Am Heart Assoc.;7(9). pii: e008796,2018 Apr 25
26	北川一夫：脳卒中領域における新年の展望　「ドクターサロン」　キョーリンメディカルサプライ　63(1) ;6-13　　ISSN 0389-7303，2018
27	北川一夫：III疾患別各論　A脳疾患　4脳梗塞　神経疾患最新の治療2018-2020　水澤英洋，山口修平，園生雅弘編集　南江堂，東京，pp105-108，ISBN978-4-524-25219-0，2018. 1. 30
28	北川一夫：脳卒中の残余リスク　炎症：新たな治療ターゲット　分子脳血管病　17: 138-144, 2018
29	飯嶋　睦：嗅覚障害.パーキンソン病（第2版）基礎･臨床研究のアップデート　日本臨床 76: 662-6, 2018
30	飯嶋　睦：嗅覚障害とパーキンソン病　生涯教育シリーズ94「わかりやすい感覚器疾患」日本医師会雑誌 147巻・特集号1: 335-6, 2018
31	飯嶋　睦：パーキンソン病治療　認知症があります．どの薬を使えばよいですか？神経内科clinical questions & peals：パーキンソン病　中外医学社　224-227, 2018
32	内山　由美子：注意障害の臨床～Attention, please!～　神経心理学34（2）155-162，2018
33	清水優子：多発性硬化の最前線　妊娠・出産と就労　Pharma Medica. 36：59-63，2018
34	清水優子：ここに注目！知っているようで知らない疾患のガイセツ　視神経脊髄炎関連疾患　Credentials.115:12-13，2018
35	矢坂正弘，藤本　茂，赤尾昌治，山崎昌子，長尾　毅（座談会）：ワルファリンとDOAC再考　心房細動における抗凝固療法　ワルファリンとDOAC再考．Cardio-Coagulation．2018;5:134-42
36	山崎昌子：血栓・塞栓症-診断・治療・予防の最新動向-基礎研究の進歩　血小板活性化機構と制御機構　日本臨床　76:1517-22，2018
37	山崎昌子：抗血小板療法，臨床に直結する血栓止血学　改訂2版　朝倉英策編著　中外医学社，東京，526-31，2018
38	横山健次, 國島伸治, 山崎昌子：2017 Hot Topics　血小板分野　血栓止血誌　29:43-5 ，2018
39	吉澤浩志, 石澤香野：1型糖尿病診療のクリニカルパール　他の併発症　4認知症　In:1型糖尿病　治療・ケアのエッセンス　内潟安子編　医歯薬出版，東京，226-233, 2018

2017

1	Kitagawa K, Hosomi N, Nagai Y, Kagimura T, Ohtsuki T, Origasa H, Minematsu K, Uchiyama S, Nakamura M, Matsumoto M; J-STARS Investigators. Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS. J Atheroscler Thromb. 1;24(10):1039-1047, 2017 Oct
2	Iwata M：Des données de Dejerine sur l’alexie à leur application à la langue japonaise. Revue Neurrologique 173 (Supp 1): S14-S15, 2017
3	Akahoshi M, Abe K, Uchiyama Y, Momose M, Fukushima K,Kitagawa K,Sakai S: Attenuation and scatter correction in I-123 FP-CIT SPECT do not affect the clinical diagnosis of dop aminergic system neurodegeneration，Medicine　96(45), pp.e8484，2017
4	Fukushima N, Yoshizawa H, Iijima M, Nagashima Y, Yamasaki K, Hagiwara N, Kitagawa K: Recurrent ischemic stroke due to caseous calcifications of mitral annulus under dual anti-platelet therapy. Neurol Clin Neurosci 5:181-2,2017
5	Iijima M, Mitoma H, Uchiyama S, Kitagawa K: Long-term Monitoring Gait Analysis Using a Wearable Device in Daily Lives of Patients with Parkinson's Disease: The Efficacy of Selegiline Hydrochloride for Gait Disturbance. Front Neurol. Oct 24;8:542,2017
6	Iijima M, Nishitani N: Cortical dynamics during simple calculation processes: A magnetoencephalography study Clin Neurophysiol Pract 2:54–61,2017
7	Matsumoto M, Sakaguchi M, Okazaki S, Hashikawa K, Takahashi T, Matsumoto M, Ohtsuki T, Shimazu T, Yoshimine T, Mochizuki H, Kitagawa K: Relationship Between Infarct Volume and Prothrombin Time-International Normalized Ratio in Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation. Circ J. 2017 Feb 24;81(3):391-396
8	Maruyama K, Uchiyama S, Shiga T, Iijima M, Ishizuka K, Hoshino T, Kitagawa K: Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation . Cerebrovasc Dis Extra. 2017;7(1):35-43.
9	Takeda T, Seilhean D, Le Ber I, Millecamps S, Sazdovitch V, Kitagawa K, Uchihara T, Duyckaerts C:Amygdala TDP-43 Pathology in Frontotemporal Lobar Degeneration and Motor Neuron Disease. J Neuropathol Exp Neurol. 1;76(9):800-812, 2017 Sep
10	Toyoda K, Minematsu K, Yasaka M, Nagai Y, Hosomi N, Origasa H, Kitagawa K, Uchiyama S, Koga M, Matsumoto M: J-STARS Investigators. The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study: Rationale and Trial Protocol. J Stroke Cerebrovasc Dis.;26(3):595-599, 2017 Mar
11	Wang X, Dalmeijer GW, den Ruijter HM, Anderson TJ, Britton AR, Dekker J, Engström G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Holewijn S, Ikeda A, Kauhanen J, Kitagawa K, Kitamura A, Kurl S, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Okazaki S, Polak JF, Price JF, Rembold CM, Rosvall M, Rundek T, Salonen JT, Sitzer M, Stehouwer CD, Tuomainen TP, Peters SA, Bots ML. Clustering of cardiovascular risk factors and carotid intima-media thickness: The USE-IMT study. PLoS One. 21;12(3):e0173393. doi: 0.1371/journal pone.0173393. eCollection 2017, 2017 Mar
12	飯嶋　睦：嗅覚障害と神経変性疾患　日本鼻科学会会誌56 (1): 65-66，2017
13	飯嶋　睦：神経変性疾患と嗅覚　味嗅覚の科学　朝倉書店　170-178，2017
14	池口亮太郎，清水優子，北川一夫：多発性硬化症（MS）と視神経脊髄炎関連疾患（NMOSD）：ホスピタリストが知っておきたい診断と治療の基礎知識　Hospitalist. 5: 181-193, 2017
15	清水優子：MSとNMOの診断と治療についての最新の知見と治療　Med Reha. 213(増刊号)：1-11，2017
16	田中正美，清水優子：多発性硬化症へのフマル酸ジメチル治療　Brain and Nerve　69（９）1041-1046　（PMID: 28900067），2017
17	矢坂正弘，山崎昌子，家子正裕，岩切龍一（座談会）：抗血栓療法における日本人(東アジア人)の特徴　グローバルデータと日本人(東アジア人)データの乖離　Cardio-Coagulation　4:142-149，2017
18	山崎昌子：超実践!脳卒中に用いる薬の基礎知識．シロスタゾール　脳神経外科速報　;27:63-68，2017
19	山崎昌子：脳梗塞2017:血栓止血学とのクロストーク　血栓を測る　脳梗塞の血栓止血学的評価　血栓止血誌　28:297-305，2017

2016

1	Kitagawa K, Miwa K, Okazaki S, Sakaguchi M, Mochizuki H. Serum high-molecular-weight adiponectin level and incident dementia in patients with vascular risk factors. Eur J Neurol.;23(3):641-7,2016 Mar
2	Hatate J, Miwa K, Matsumoto M, Sasaki T, Yagita Y, Sakaguchi M, Kitagawa K, Mochizuki H. Association between cerebral small vessel diseases and mild parkinsonian signs in the elderly with vascular risk factors. Parkinsonism Relat Disord.;26:29-34,2016 May
3	Iijima M, Osawa M, Uchiyma S, Kitagawa K：Odor identification function differs between vascular parkinsonism and akinetic-type Parkinson’s disease. J Alzheimers Dis Parkinsonism 6:1, 2016
4	Ishizuka K, Hoshino T, Shimizu S, Shirai Y, Mizuno S, Toi S, Maruyama K, Uchiyama S, Kitagawa K. Brachial-ankle pulse wave velocity is associated with 3-month functional prognosis after ischemic stroke. Atherosclerosis. Dec;255:1-5,2016
5	Miwa K, Okazaki S, Sakaguchi M, Mochizuki H, Kitagawa K. Interleukin-6, interleukin-6 receptor gene variant, small-vessel disease and incident dementia. Eur J Neurol.;23(3):656-63,2016
6	Miwa K, Tanaka M, Okazaki S, Yagita Y, Sakaguchi M, Mochizuki H, Kitagawa K: Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors. J Alzheimers Dis.;49(2):503-13,2016
7	Nagatsuka K, Miyata S, Kada A, Kawamura A, Nakagawara J, Furui E, Takiuchi S, Taomoto K, Kario K, Uchiyama S, Saito K, Nagao T, Kitagawa K, Hosomi N, Tanaka K, Kaikita K, Katayama Y, Abumiya T, Nakane H, Wada H, Hattori A, Kimura K, Isshiki T, Nishikawa M, Yamawaki T, Yonemoto N, Okada H, Ogawa H, Minematsu K, Miyata T. Cardiovascular events occur independently of high on-aspirin platelet reactivity and residual COX-1 activity in stable cardiovascular patients. Thromb Haemost. 1;116(2):356-68,2016 Aug
8	Perera KS, Vanassche T, Bosch J, Swaminathan B, Mundl H, Giruparajah M, Barboza MA, O'Donnell MJ, Gomez-Schneider M, Hankey GJ, Yoon BW, Roxas A Jr, Lavallee P, Sargento-Freitas J, Shamalov N, Brouns R, Gagliardi RJ, Kasner SE, Pieroni A, Vermehren P, Kitagawa K, Wang Y, Muir K, Coutinho JM, Connolly SJ, Hart RG; ESUS Global Registry Investigators. Global Survey of the Frequency of Atrial Fibrillation-Associated Stroke: Embolic Stroke of Undetermined Source Global Registry. Stroke.;47(9):2197-2202,2016 Sep
9	Perera KS, Vanassche T, Bosch J, Swaminathan B, Mundl H, Giruparajah M, Barboza MA, O'Donnell MJ, Gomez-Schneider M, Hankey GJ, Yoon BW, Roxas A Jr, Lavallee P, Sargento-Freitas J, Shamalov N, Brouns R, Gagliardi RJ, Kasner SE, Pieroni A, Vermehren P, Kitagawa K, Wang Y, Muir K, Coutinho JM, Connolly SJ, Hart RG; ESUS Global Registry Investigators. Global Survey of the Frequency of Atrial Fibrillation-Associated Stroke: Embolic Stroke of Undetermined Source Global Registry. Stroke.;47(9):2197-2202,2016 Sep
10	Shimizu Y, Fujihara K, Ohashi T, Nakashima I, Yokoyama K, Ikeguch R, Takahashi T, Misu T, Shimizu S, Aoki M, Kitagawa K. Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder. Mult Scler.;22(11):1413-1420,2016 Oct
11	Takeda T, Konno A, Kazama T, Suzuki M, Shimizu Y, Iijima M, Tanaka J, Kitagawa K. Acquired hemophilia A associated with myasthenia gravis and Isaacs' syndrome. J Neurol Sci. 15;369:210-211,2016 Oct
12	Watanabe A, Sasaki T, Yukami T, Kanki H, Sakaguchi M, Takemori H, Kitagawa K, Mochizuki H. Serine racemase inhibition induces nitric oxide-mediated neurovascular protection during cerebral ischemia. Neuroscience. 17;339:139-149,2016 Dec
13	Yamazaki M, Ohnishi T, Hosokawa K, Yamaguchi K, Yoneyama T, Kawashima A, Okada Y, Kitagawa K, Uchiyama S. Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy. J Thromb Haemost.;14(9):1788-1797,2016 Sep
14	北川一夫：（特集　脳卒中）　ESUS(embolic stroke of undetermined sources)　日本臨床74(4):597-602，2016.4
15	内山　由美子：診療の秘訣　不眠症状にひそむ神経疾患　Modern Physician　36(11),1226，2016
16	清水優子：性差学の多発性硬化症・視神経脊髄炎治療の応用　最新医学.71:1168-1175，2016
17	冨山佳昭, 佐藤金夫, 尾崎由基男, 清水美衣, 田村典子, 西川政勝, 野村昌作, 堀内久徳, 松原由美子, 矢冨裕, 山崎昌子, 羽藤高明：学術標準化委員会血小板部会．「透過光血小板凝集検査法の標準化　国際血栓止血学会血小板機能標準化部会からの提言」の紹介と解説　血栓止血誌　;27:365-9，2016
18	山崎昌子，後藤信哉：抗血栓療法部会　血栓止血誌;27:575-7，2016

2015

1	Kitagawa K, Miwa K, Yagita Y, Okazaki S, Sakaguchi M, Mochizuki H:Association between carotid stenosis or lacunar infarction and incident dementia in patients with vascular risk factors. Eur J Neurol.;22(1):187-92,2015 Jan
2	Adachi U, Tsutsumi Y, Iijima M, Mizuno S, Uchiyama S, Kitagawa K:Differences in Endothelial Function between Ischemic Stroke Subtypes. J Stroke Cerebrovasc Dis.;24(12):2781-6, 2015 Dec
3	Gijsberts CM, Groenewegen KA, Hoefer IE, Eijkemans MJ, Asselbergs FW, Anderson TJ, Britton AR, Dekker JM, Engström G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Holewijn S, Ikeda A, Kitagawa K, Kitamura A, de Kleijn DP, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Okazaki S, O'Leary DH, Pasterkamp G, Peters SA, Polak JF, Price JF, Robertson C, Rembold CM, Rosvall M, Rundek T, Salonen JT, Sitzer M, Stehouwer CD, Bots ML, den Ruijter HM:Race/Ethnic Differences in the Associations of the Framingham Risk Factors with Carotid IMT and Cardiovascular Events. PLoS One. 2;10(7):e0132321,2015 Jul
4	Hino S, Sasaki S: Flail arm syndrome with cytoplasmic vacuoles in remaining anterior horn motor neurons: A peculiar variant of amyotrophic lateral sclerosis.Neuropathology 35 (6):582-6, 2015
5	Hoshino T, Nagao T, Shiga T, Maruyama K, Toi S, Mizuno S, Ishizuka K, Shimizu S, Uchiyama S, Kitagawa K:Prolonged QTc interval predicts poststroke paroxysmal atrial fibrillation. Stroke.;46(1):71-6,2015 Jan
6	Hosomi N, Nagai Y, Kohriyama T, Ohtsuki T, Aoki S, Nezu T, Maruyama H, Sunami N, Yokota C, Kitagawa K, Terayama Y, Takagi M, Ibayashi S, Nakamura M, Origasa H, Fukushima M, Mori E, Minematsu K, Uchiyama S, Shinohara Y, Yamaguchi T, Matsumoto M; J-STARS collaborators. The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel- group Study. EBioMedicine.;2(9):1071-8,2015 Aug 6
7	Iijima M, Osawa M, Maruyama K, Uchiyama S, Kitagawa K:Self-Reported Adherence after overnight switching from immediate- to extended-release pramipexole in Parkinson’s disease. Advanced in Parkinson’s disease 4:13-19, 2015
8	Iijima M, Mase R, Osawa M, Shimizu S, Uchiyama S: Event-related synchronization and desynchronization of high-frequency electroencephalographic activity during a visual Go/No-Go paradigm. Neuropsychobiology 71:17–24, 2015
9	Iijima M, Osawa M, Uchiyama S, Kitagawa K:Pramipexole-induced antecollis in patients with Parkinson's disease: Two cases and literature review. eNeurologicalSci 1: 21–23,2015
10	Inose Y, Kato Y, Kitagawa K, Uchiyama S, Shibata N:Activated microglia in ischemic stroke penumbra upregulate MCP-1 and CCR2 expression in response to lysophosphatidylcholine derived from adjacent neurons and astrocytes. Neuropathology. Jun;35(3):209-23,2015
11	Nakamura M,Isshiki T,Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Ikeda Y, Saito S:Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: Post-hoc analysis of the randomized PRASFIT-ACS study International Journal of Cardiology 1;182:541-548,2015
12	Nomura E, Suzuki A, Inoue I, Nakagawara J, Takahashi K, Takahashi T, Manabe Y, Yokota C, Okada K, Nishihara T, Yamamoto Y, Noda K, Takahashi S, Ibayashi S, Takagi M, Kitagawa K, Tanahashi N, Kuriyama M, Hirata K, Hosomi N, Minematsu K, Kobayashi S, Matsumoto M: J-STARS-L Investigators. Subsequent Vascular Events after Ischemic Stroke: The Japan Statin Treatment against Recurrent Stroke-Longitudinal. J Stroke Cerebrovasc Dis.;24(2):473-9,2015 Feb
13	Sakaguchi M, Kitagawa K, Okazaki S, Yoshioka D, Sakata Y, Mochizuki H, Sawa Y, Yoshimine T: Sulcus subarachnoid hemorrhage is a common stroke subtype in patients with implanted left ventricular assist devices. Eur J Neurol.;22(7):1088-93,2015 Jul
14	Sasaki S: Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis. Neuropathology 35(6):518-528, 2015
15	Sasaki S, Iguchi Y, Katsuno M, Sobue G: Alterations in the blood-spinal cord barrier in TDP-43 conditional knockout mice. Neurosci Lett 26 (598) :1-5, 2015
16	Sasaki S: Sporadic lower motor neuron disease with a snake eyes appearance on the cervical anterior horns by MRI. Clin Neurol Neurosurg 136:122-31, 2015
17	Sasaki S, Yamashita T, Kwak S: Autophagy in spinal motor neurons of conditional ADAR2-knockout mice: An implication for a role of calcium in increased autophagy flux in ALS. Neurosci Lett 26 (598) :79-84, 2015
18	Takeda T, Iijima M, Uchihara T, Ohashi T, Seilhean D, Duyckaerts C, Uchiyama S:TDP-43 pathology progression along the olfactory pathway as a possible substrate for olfactory impairment in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 74 (6): 547-56,2015.
19	Takizawa S, Tanaka F, Nishiyama K, Hasegawa Y, Nagata E, Mizuma A, Yutani S, Nakayama T, Kobayashi H, Yanagimachi N, Okazaki T, Kitagawa K:CMB-NOW Study Investigators. Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial. J Stroke Cerebrovasc Dis. 2015 Sep;24(9):2143-8.
20	Yukami T, Yagita Y, Sugiyama Y, Oyama N, Watanabe A, Sasaki T, Sakaguchi M, Mochizuki H, Kitagawa K:Chronic Elevation of Tumor Necrosis Factor-α Mediates the Impairment of Leptomeningeal Arteriogenesis in db/db Mice. Stroke. Jun;46(6):1657-63,2015
21	北川一夫：特集Ⅱ.脳微小出血 (microbleeds)　脳微小出血と炎症分子脳血管病先端医学社　vol14(1):52-54，2015
22	北川一夫：脳におけるROCKの役割（脳虚血の観点から）メディカル・ビューポイント(MVP) 医事出版社　4;vol36(2)，2015
23	北川一夫：(特集)2.脳小血管病と血管性認知症　その予防と治療戦略　脳血管病への炎症機転の関与「Dementia Japan」　日本認知症学会　29(1)44-50，2015.1
24	北川一夫： (カラーグラビア)脳血管障害を診る　～形態と機能障害の面から～　「日本認知症学会」　メディカルレビュー社　vol26(1)7-11，2015.2
25	北川一夫：(総論)脳虚血の基礎と病態　「Medical Science Digest 」　北隆館／ニュー・サイエンス社　vol41(3):7-8，2015.3
26	北川一夫：(特集Ⅱ)心房細動に伴う心原性脳塞栓症　心房細動による心原性脳塞栓症の現状　「神経内科」　科学評論社　vol82(1)105-109，2015.1
27	北川一夫：脳梗塞治療における再生医療の可能性　「診断と治療」　診断と治療社　103(1): 115-118，2015
28	北川一夫：タボリック症候群の管理と脳卒中予防Mebio　32:2-8, 2015
29	飯嶋　睦，吉澤浩志，戸田晋央：パーキンソン病における嗅覚障害、前頭葉機能と歩行障害との関連に関する研究　厚生労働科学研究費補助金　医療技術実用化総合研究事業　平成26年度報告書 47-8，2015
30	飯嶋　睦：認知症と嗅覚障害. Progress in Medicine 35(4): 693-5, 2015
31	飯嶋　睦：パーキンソン病の治療—変貌する概念と治療戦略　非運動症状とその治療　Current Therapy 33(10): 990-3, 2015
32	内山　由美子：私の処方　易怒性の強いアルツハイマー型認知症に　Modern Physician　35(12)　1493，2015
33	清水優子：免疫性神経疾患患者の妊娠・出産時の対応と治療　日本臨牀　73（臨増）877-883，2015
34	清水優子：感覚障害を呈する疾患の鑑別と診断　神経梅毒.Clinical Neuroscience. 33:583-585，2015
35	長尾毅彦：老化と虚血性脳血管障害　血栓止血誌26: 272-275，2015
36	長尾毅彦：経口抗凝固薬の臨床試験とエビデンス　脳と循環 20: 127-133，2015
37	長尾毅彦：薬物療法　抗凝固療法　Modern Physician　35: 624-628， 2015
38	長尾毅彦：血栓・塞栓症治療と予防：抗血小板薬　臨牀と研究92: 292-295，2015
39	樋口瑛子, 内山　由美子, 飯嶋　睦, 北川　一夫：抗凝固薬が症状の進行抑制に有用と考えられたアテローム血栓性脳梗塞の1例　脳卒中37　446-451，2015
40	山崎昌子：虚血性脳血管障害の抗血小板療法　新・血栓止血血管学　検査と診療　一瀬白帝，丸山征郎，村田満編　金芳堂　京都　pp.156-163，2015

2014

1	Uchiyama S, Hori M, Matsumoto M, Tanahashi N, Momomura S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Ueda H, lekushi K, Yamanaka S, Tajiri M; J-ROCKET AF Study Investigators: Net clinical benefit of rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation: a subgroup analysis of J-ROCKET AF. J Stroke Cerebrovasc Dis 23:1142-1147, 2014
2	Uchiyama S: The concept of acute cerebrovascular syndrome. Front Neurol Neurosci 33:11-18, 2014
3	Fujimoto K, Fujishiro M, Kato M, Higuch K, Iwakiri R, Sakamoto C, Uchiyama S, Kashiwagi A, Ogawa H, Murakami K, Mine T, Yoshino J, Kinoshita Y, Ichinose M, Matsui T; Japan Gastroenterological Endoscopy Society: Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. J Gastroendoscopy 26:1-14, 2014
4	Lu Y,　Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G; Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration: Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1-8 million participants. Lancet 383:970-983, 2014
5	Ikeguchi R, Shimizu Y, Suzuki S, Shimizu S, Kabasawa C, Hashimoto S, Masuda M, Nagane Y, Utsugisawa K, Suzuki Y, Takahashi T, Utsumi H, Fujihara K, Suzuki N, Uchiyama S. Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature. Clin Neurol Neurosurg. 125: 217-221, 2014
6	Ito E, Sonoo M, Iwanami T, Shimizu T, Iwata M:Can palm stimulation differentiate diabetic polyneuropathy from carpal tunnel syndrome? J Clin Neurophysiol 31(2): 169-174, 2014
7	Maruyama K, Shiga T, Iijima M, Moriya S, Mizuno S, Toi S, Arai K, Ashihara K, Abe K, Uchiyama S: Brain natriuretic peptide in acute ischemic stroke. J Stroke Cerebrovasc Dis 23:967-972, 2014
8	Miwa K, Tanaka M, Okazaki S, Yagita Y, Sakaguchi M, Mochizuki H, Kitagawa K. Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors. Neurology 83(7):646-653, 2014
9	Moriya S, Yamazaki M, Murakami H, Maruyama K, Uchiyama S:Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE. J Stroke Cerebrovasc Dis. 23:2540-2546, 2014
10	Nagai Y, Kohriyama T, Origasa H, Minematsu K, Yokota C, Uchiyama S, Ibayashi S, Terayama Y, Takagi M, Kitagawa K, Nomura E, Hosomi N, Ohtsuki T, Yamawaki T, Matsubara Y, Nakamura M, Yamasaki Y, Mori E, Fukushima M, Kobayashi S, Shinohara Y, Yamaguchi T, Matsumoto M; J-STARS Investigators. Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS). Int J Stroke 9: (2):232-239, 2014
11	Okazaki S, Sakaguchi M, Miwa K, Furukado S, Yamagami H, Yagita Y, Mochizuki H, Kitagawa K. Association of interleukin-6 with the progression of carotid atherosclerosis: a 9-year follow-up study. Stroke 45(10):2924-2929, 2014
12	Sasaki S, Takenari Yamashita, Hideyama T, Kwak S : Unique nuclear vacuoles in the motor neurons of conditional ADAR2-knockout mice. Brain Res 6 (1550) :36-46, 2014
13	Sasaki S, Horie Y: The Effects of an uninterrupted switch from donepezil to galantamine without dose titration on behavioral and psychological symptoms of dementia in Alzheimer's disease. Dement Geriatr Cogn Dis Extra 4:131-139, 2014
14	Takeda T, Uchihara T, Nakayama Y, Nakamura A, Sasaki S, Kakei S, Uchiyama S, Duychaerts C, Yoshida M: Dendritic retraction, but not atrophy, is consistent in amyotrophic lateral sclerosis-comparison between Onuf’s neurons and other sacral motor neurons. Acta Neuropathol Commun 2: 11, 2014
15	Tanaka K, Uehara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Takagi S, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Nagao T, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K. Features of patients with transient monocular blindness: a multicenter retrospective study in Japan. J Stroke Cerebrovasc Dis 23:e151-e155, 2014
16	Toyoda K, Yasaka M, Uchiyama S, Iwade K, Koretsune Y, Nagata K, Sakamoto T, Nagao T, Yamamoto M, Gotoh J, Takahashi JC, Minematsu K; Bleeding with Antithrombotic Therapy Study Group: CHADS2 and CHA2DS2-VASc scores as bleeding risk indices for patients with atrial fibrillation: the Bleeding with Antithrombotic Therapy Study. Hypertens Res 37:463-466, 2014
17	Uehara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Takagi S, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Nagao T, Uchiyama S, Matsumoto M, Iihara K, Minematsu K. Factors associated with onset-to-door time in patients with transient ischemic attack admitted to stroke centers. Stroke 45:611-613, 2014
18	Uemura N, Sugano K, Hiraishi H, Shimada K, Goto S, Uchiyama S, Okada Y, Origasa H, Ikeda Y; MAGIC Study Group: Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-rsik cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol 49:814-824, 2014
19	Yoshizawa H, Gazes, Stern Y, Miyata Y, Uchiyama S: Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve Psychiatry Res 221:78-85, 2014
20	内山真一郎、杉　薫、是恒之宏、矢坂正弘：抗凝固療法の展望と課題. 医薬ジャーナル 50:734-744, 2014
21	内山真一郎：内科治療の変遷と展望. 最新臨床脳卒中学（上）-最新の診断と治療-. 日本臨床72（増刊5）:13-19, 2014
22	内山真一郎、松本昌泰、塩川芳昭、鈴木倫保、片山泰朗、阿部康二：脳卒中研究・臨床におけるトピックス2014　分子脳血管病 13:1-8, 2014
23	内山真一郎：急性脳血管症候群としての一過性脳虚血発作　東女医大誌　84:E8-E16, 2014
24	北川一夫：脳梗塞の治療　慢性期治療　降圧療法　日本臨床　72 Suppl 7, 87-92, 2014
25	北川一夫：心房細動治療（薬物）ガイドライン（2013年改訂版）International Review of Thrombosis 9: 162-168, 2014
26	飯嶋　睦：パーキンソン病の嗅覚障害　Medical Science Digest 40: 16-8, 2014
27	飯嶋　睦：パーキンソン病の早期診断における検査法　東女医大誌84: 35-41, 2014
28	池口亮太郎，清水優子，清水　悟，小林正樹，内山真一郎：多発性硬化症、視神経脊髄炎、中枢神経浸潤を伴う悪性リンパ腫の鑑別におけるIgG index、髄液インターロイキンー6・可溶性インターロイキンー2受容体・ミエリン塩基性蛋白の有用性　東女医大誌84(E1):E141-E148, 2014
29	猪瀬悠理，柴田亮行，内山真一郎：虚血性ペナンブラにおける分子病理　Molecular Pathology in Ischemic Penumbra　東女医大誌84（臨増） E1:91-E101：2014
30	内山由美子, 岩田　誠, 内山真一郎：変性疾患に生じる言語障害　発話障害を中心に　東女医大誌84（臨増）E80-E85，2014
31	内山由美子，岩田　誠，内山真一郎：前頭葉背外側面の脳梗塞による超皮質性運動失語　東女医大誌84（臨増）E178-E183, 2014
32	江郷茉衣，武田貴裕，伊藤英一，清水優子，内山真一郎：脳内錐体路に異常を認めた亜急性精髄連合変性症の１例　神経画像アトラス　BRAIN and NERVE　神経研究の進歩 66:70-71, 2014
33	樺澤千昌，木村友美，内山由美子，岩田　誠，内山真一郎：感染性心内膜炎に合併した多発脳膿瘍と脊髄内膿瘍の１例　東女医大誌84（臨増）: E192-E196, 2014
34	木村友美，内山真一郎：微小循環モデルにおけるシロスタゾールとGPIIb/IIIa阻害薬の血液レオロジーに及ぼす影響. 東女医大誌 84:E111-E117, 2014
35	小林正樹，竹内恵，鈴木美紀，内山真一郎：家族性低カリウム性周期性四肢麻痺が疑われる慢性ミオパチーの1例　東女医大誌 84:E188-E191, 2014.
36	小林正樹，竹内恵，鈴木美紀，内山真一郎：家族性低カリウム性周期性四肢麻痺が疑われる慢性ミオパチーの1例　東女医大誌 84:E188-E191, 2014.
37	清水優子：【内科疾患　最新の治療　明日への指針】第7章　神経・筋　多発性硬化症　内科　113:1406-1409，2014
38	清水優子：妊娠出産への対応.Clinical Neuroscience. 32：1302-1304，2014
39	清水優子：ここに注目！知っているようで知らない疾患のトリセツ　多発性硬化症.Credentials. 74:14-15，2014
40	清水優子：多発性硬化症および類似疾患の治療の実際　フィンゴリモドの位置づけ　MS　Frontier. 3：32-36，2014
41	Suzuki M, Takeuchi M, Uchiyama Y, Uchiyama S: Vasculitic Neuropathy in a Patient with POEMS Syndrome，東女医大誌84（臨増）E174-E177，2014
42	鈴木美紀，竹内　恵，内山真一郎：ニューロパチーの診断と治療　日常診療でよく見る疾患を中心に　東女医大誌　84:E73-E79,2014
43	鈴木美紀，竹内恵，内山由美子，内山真一郎：血管炎性ニューロパチーを呈したPOEMS症候群の１例. 東女医大誌 84:E174-E177, 2014
44	竹内恵，内山真一郎，荻野美恵子，鈴木則宏，亀井聡：内科系診療における技術評価-「もの」から「技術」への転換をめざして. 内科系20領域における診療報酬上の課題.　神経関連委員会　内科系20領域における診療報酬上の課題　神経関連委員会　日内科会誌 103:3045-3048, 2014
45	竹内　恵，小林正樹，鈴木美紀：血管炎性ニューロパチーの診断と治療　東女医大誌84（臨増）E24-E28，2014
46	武田貴裕，飯島睦，内山真一郎：筋委縮性側索硬化症における嗅覚障害東女医大誌 84:E129-E134, 2014
47	Tsutsumi Y, Uchiyama Y, Uchiyama S:MR Imaging and Clinical Course in Transverse Sinus Thrombosis，東女医大誌84（臨増）E155-E158，2014
48	Nagao T, Uchiyama S : The usefulness of new anticoagulant drugs for patients with cardioembolic stroke. J Tokyo Women’s Univ; 84 suppl1: E42-8，2014
49	長尾毅彦，内山真一郎：抗血栓療法と出血性合併症. 抗血栓療法と頭蓋内出血　脳と循環　19:123-127, 2014
50	長尾毅彦：心房細動患者における脳卒中二次予防効果　医薬ジャーナル; 50: 683-689，2014
51	長尾毅彦：脳血管障害急性期の診断と治療に必要な血液検査　アクチュアル脳・神経疾患の臨床シリーズ「脳血管障害治療最前線」　中山書店，2014
52	長尾毅彦：心房細動症例における脳梗塞予防のエビデンス　老年医学; 52: 1445-1450，2014
53	長尾毅彦：治療薬解説　新規経口抗凝固薬　カレントテラピー; 32: 1233-1237，2014
54	長尾毅彦：抗凝固療法中の頭蓋内出血　ーワルファリン vs 新規経口抗凝固薬ー　Cardio-Coagulation; 1: 163-167，2014
55	長尾毅彦：脳梗塞の画像診断　ーCTおよびMRI・MRAを中心にー　医学と薬学; 71: 1331-1336，2014
56	長尾毅彦，加来浩平，菅波秀規：SGLT2阻害薬は虚血性脳卒中発症を増やすのか？　トホグリフロジン臨床開発試験の分析　医薬ジャーナル; 50: 2295-2301，2014
57	長尾毅彦：全身管理　日本臨牀2014年増刊７（最新臨床脳卒中学下巻）; 72 suppl7: 47-51，2014
58	長尾毅彦：TTR（time in therapeutic range）　分子脳血管病; 13: 185-188，2014
59	長尾毅彦：脳卒中における血小板活性化とその制御　脳神経外科; 42: 879-885，2014
60	長尾毅彦：脳血管障害における抗凝固療法の基本　有病者歯科医療; 23: 2-6，2014
61	長尾毅彦：抗凝固療法の進化脳卒中; 36: 220-222，2014
62	長尾毅彦：抗血小板療法と頭蓋内出血　脳と循環; 19: 123-127，2014
63	長尾毅彦：血栓溶解薬（t-PAを中心に）日本臨牀; 72: 1254-1257，2014
64	長尾毅彦：急性脳血管症候群（ACVS: acute cerebrovascular syndrome）の提唱　日本臨牀 2014年増刊５（最新臨床脳卒中学上巻）; 72 suppl5: 69-71，2014
65	中村智実，鶴田信慈，内山真一郎：シロスタゾールは急性脳梗塞患者に頸動脈硬化変化を６か月間で退縮させる. 東女医大誌 84:E123-E128, 2014
66	中村智実，内山真一郎：脳梗塞再発予防のためのより良い抗血小板療法を目指して　東女医大誌 84:E66-E72, 2014
67	中村智実，内山真一郎：アテローム血栓症とRAS　アテローム血栓症の概念と疫学　Angiotesin Research 11:61-66，2014
68	星野岳郎，石塚健太郎，長尾毅彦，内山真一郎：当科におけるダビガトランエテキシラートの使用実態　東女医大誌 84:E149-E154, 2014
69	益田陽子，赫　洋美，竹内　恵，岩田　誠，内山真一郎：発作性・反復性の神経症状を認めた髄膜癌腫症東女医大誌 84（臨増）E184-187, 2014
70	松村美由紀，内山真一郎：Trail Making Test Part Bによる軽度認知機能障害患者の認知症への進行予測. 東女医大誌 84:E107-E110, 2014
71	丸山健二，志賀剛，飯島睦，内山真一郎：急性期脳梗塞における非弁膜症性心房細動とbrain natriuretic peptide (BNP)の関係. 東女医大誌 84:E118-E122, 2014
72	宮崎一秀，内山真一郎，岩田　誠，山本健詞，岡山健次：右利き交叉性失語を呈しMRIにて皮質層状壊死を認め不完全脳梗塞による選択的神経細胞死が疑われた１例　東女医大誌84（臨増）E167-173, 2014
73	守屋里織，山崎昌子，村上博彦，丸山健二，赫　洋美，内山真一郎．終末糖化産物受容体(soluble receptor for advanced glycation endproducts:sRAGE)のメタボリック症候群におけるバイオマーカーとしての意義　アディポネクチンとの比較　東女医大誌　84臨増1:E135-E140，2014
74	山崎昌子，内山真一郎：抗血小板・抗凝固薬療法-循環器医のための治療のコツと落とし穴-　診る　効果と出血リスクをどのように診るか　抗血小板薬　Heart View　18:128-134，2014
75	山崎昌子，内山真一郎：抗血小板薬の薬効評価　東女医大誌 84:E49-E56, 2014
76	山崎昌子，内山真一郎：抗血小板療法の進化　脳梗塞再発予防に対する抗血小板薬の選択と新規開発薬　脳卒中 36:210-215, 2014
77	山崎昌子，内山真一郎：神経症候群（第２版）-その他の神経疾患を含めて-　内科疾患にみられる神経障害（疾患）血液疾患　血液凝固異常　日本臨床（別冊神経症候学V）:465-469, 2014
78	山崎昌子，内山真一郎：脳卒中EBMカタログII 慢性期の抗血小板療法　CAPRIE、CHARISMA、MATCH、SPS3　Clinical Neuroscience;32:1128-1132，2014
79	山崎昌子：進化する脳卒中治療　抗血栓療法の新たなエビデンス　Secondary Prevention of Small Subcortical Stroke(SPS3)試験　神経治療学　31:334-339， 2014
80	山崎昌子，内山真一郎：脳梗塞・一過性脳虚血発作の治療　再発予防のための抗血小板薬，脳血管障害の治療最前線　辻省次総編集　中山書店，東京，234-239，2014
81	吉澤浩志，内山真一郎：認知機能の加齢性変化と認知予備能　東女医大誌 84:E57-E65, 2014

研究テーマ/業績

業績

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014